Parkinsonism & Related Disorders
Volume 15, Issue 9 , Pages 627-632 , 5 November 2009

A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction

  • Andreas Puschmann

      Affiliations

    • Department of Neurology, Lund University Hospital, Sweden
    • Department of Clinical Science, Section of Geriatric Psychiatry, Lund University, Sweden
    • Corresponding Author InformationCorresponding author. Department for Neurology, Lund University Hospital, Getingevägen 4, 22185 Lund, Sweden. Tel.: +46 46 175421/+46 46 171000; fax: +46 46 177940.
    • ,
  • Owen A. Ross

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Carles Vilariño-Güell

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Sarah J. Lincoln

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Jennifer M. Kachergus

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Stephanie A. Cobb

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Suzanne G. Lindquist

      Affiliations

    • Division of Neurogenetics, Rigshospitalet Copenhagen University Hospital, Denmark
    • ,
  • Jørgen E. Nielsen

      Affiliations

    • Institute of Cellular and Molecular Medicine, Section of Neurogenetics, University of Copenhagen, The Panum Institute, Denmark
    • Memory Disorders Research Unit, Rigshospitalet, Copenhagen University Hospital, Denmark
    • ,
  • Zbigniew K. Wszolek

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Matthew Farrer

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Håkan Widner

      Affiliations

    • Department of Neurology, Lund University Hospital, Sweden
    • ,
  • Danielle van Westen

      Affiliations

    • Department of Radiology, Lund University Hospital, Sweden
    • ,
  • Douglas Hägerström

      Affiliations

    • Department of Clinical Neurophysiology, Lund University Hospital, Sweden
    • ,
  • Katerina Markopoulou

      Affiliations

    • University of Thessaly, Medical School, Larissa, Greece
    • ,
  • Bruce A. Chase

      Affiliations

    • Department of Biology, University of Nebraska at Omaha, Omaha, NE, USA
    • ,
  • Karin Nilsson

      Affiliations

    • Department of Clinical Science, Section of Geriatric Psychiatry, Lund University, Sweden
    • ,
  • Jan Reimer

      Affiliations

    • Department of Neurology, Lund University Hospital, Sweden
    • ,
  • Christer Nilsson

      Affiliations

    • Department of Clinical Science, Section of Geriatric Psychiatry, Lund University, Sweden
    • Department of Cognitive Medicine, Lund University Hospital, Sweden

Received 15 March 2009 ,Revised 22 May 2009 ,Accepted 19 June 2009.

References 

  1. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology. 1999 Jan;56(1):33–39
  2. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Annals of Neurology. 1992;32(Suppl.):S125–127
  3. Lundborg H. Medizinisch-biologische Familienforschungen innerhalb eines 2232köpfigen Bauerngeschlechtes in Schweden (Provinz Blekinge). Jena: Verlag von Gustav Fischer; 1913;
  4. Mjönes H. Paralysis agitans. A clinical and genetic study. Acta Psychiatrica et Neurologica Supplementum. 1949;54:195
  5. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Annals of Neurology. 1990 Mar;27(3):276–282
  6. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Annals of Neurology. 1995 Sep;38(3):373–378
  7. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (New York, NY. 1997 Jun 27;276(5321):2045–2047
  8. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA. Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism. Annals of Neurology. 1999 Sep;46(3):374–381
  9. Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Experimental Neurology. 1998 Dec;154(2):684–690
  10. Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, et al. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Molecular Psychiatry. 1998 Nov;3(6):493–499
  11. Athanassiadou A, Voutsinas G, Psiouri L, Leroy E, Polymeropoulos MH, Ilias A, et al. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. American Journal of Human Genetics. 1999 Aug;65(2):555–558
  12. Veletza S, Bostatzopoulou S, Hantzigeorgiou G, Kazis A, Papadimitriou A. α-Synuclein mutation associated with familial Parkinson's disease in two new Greek kindreds (abstract). Journal of Neurology. 1999;246(Suppl. 1):1–43
  13. Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance?. Neurology. 1999 Feb;52(3):651–654
  14. Bostantjopoulou S, Katsarou Z, Papadimitriou A, Veletza V, Hatzigeorgiou G, Lees A. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Movement Disorders. 2001 Nov;16(6):1007–1013
  15. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Annals of Neurology. 2001 Mar;49(3):313–319
  16. Berg D, Niwar M, Maass S, Zimprich A, Moller JC, Wuellner U, et al. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Movement Disorders. 2005 Sep;20(9):1191–1194
  17. Michell AW, Barker RA, Raha SK, Raha-Chowdhury R. A case of late onset sporadic Parkinson's disease with an A53T mutation in alpha-synuclein. Journal of Neurology, Neurosurgery, and Psychiatry. 2005 Apr;76(4):596–597
  18. Michell AW. Personal communication. 2008 October 22. [Cited with permission].
  19. Ki CS, Stavrou EF, Davanos N, Lee WY, Chung EJ, Kim JY, et al. The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease. Clinical Genetics. 2007 May;71(5):471–473
  20. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nature Medicine. 1998 Nov;4(11):1318–1320
  21. Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schule B, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007 Mar 20;68(12):916–922
  22. Puschmann A, Wszolek ZK, Farrer M, Gustafson L, Widner H, Nilsson C. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?. Parkinsonism Related Disorders. 2009 June;15(5):390–392
  23. Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, et al. LRRK2 mutations are a common cause of Parkinson's disease in Spain. European Journal of Neurology. 2006 Apr;13(4):391–394
  24. Rocca WA, Maraganore DM, McDonnell SK, Schaid DJ. Validation of a telephone questionnaire for Parkinson's disease. Journal of Clinical Epidemiology. 1998 Jun;51(6):517–523
  25. Puschmann A. Unverricht-Lundborg disease-A misnomer?. Movement Disorders. 2009 March 15;24(4):629–630
  26. Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Annals of Neurology. 1996 Nov;40(5):767–775
  27. Papapetropoulos S, Ellul J, Paschalis C, Athanassiadou A, Papadimitriou A, Papapetropoulos T. Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece. European Journal of Neurology. 2003 May;10(3):281–286
  28. Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, et al. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease. Acta Neuropathologica. 2008 Jul;116(1):25–35
  29. Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, et al. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Experimental Neurology. 2004 Jun;187(2):279–288
  30. Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathologica. 2002 Jul;104(1):7–11

PII: S1353-8020(09)00152-7

doi: 10.1016/j.parkreldis.2009.06.007

Parkinsonism & Related Disorders
Volume 15, Issue 9 , Pages 627-632 , 5 November 2009

Article Tools

* Image Usage & Resolution